Your search returned 2 results.

Results
	1.	Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients. [electronic resource] by Mata-Marín, José Antonio Smeke, Ariane Estrella Weiser Rodriguez, Mariana Rotzinger Chávez-García, Marcelino Banda-Lara, Marco Isaac Rios, Alma Minerva Pérez Nuñez-Rodríguez, Nohemí Domínguez-Hermosillo, Juan Carlos Sánchez, Alberto Chaparro Juarez-Kasusky, Irene Herrera, Javier Enrique Cruz Ramírez, Jorge Luis Sandoval Gaytán-Martínez, Jesús Producer: 20170503 In: Drugs in R&D vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. [electronic resource] by Shiffman, Mitchell L Cheinquer, Hugo Berg, Christoph P Berg, Thomas de Figueiredo-Mendes, Cláudio Dore, Gregory J Ferraz, Maria Lúcia Mendes-Corrêa, Maria Cássia Lima, Maria Patelli Parise, Edison R Rios, Alma Minerva Perez Reuter, Tania Sanyal, Arun J Shafran, Stephen D Hohmann, Marc Tatsch, Fernando Bakalos, George Zeuzem, Stefan Producer: 20150728 In: Hepatology international vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search